Distribution and trend of antibiotics resistance of extended- spectrum β- lactamases- producing Escherichia coil and Klebsiella pneumoniae in the late three years
陈亚红,姚婉贞,刘振英,赵鸣武
DOI: https://doi.org/10.3969/j.issn.1001-8689.2003.12.005
2003-01-01
Abstract:Objective: To investigate the pathogenic distribution and trend of antibiotics resistance of extended-spectrum β-lactamases (ESBLs)-producing Escherichia coil and Klebsiella pneumoniae in the late three years in our hospital. Methods: E. coli and K. pneumoniae were collected from January, 2000 to October, 2002. ESBLs-producing isolates were detected by inhibitor-potentiated disc diffusion test and the bacterial susceptibility test against 17 antibacterial agents was performed by agar dilution test. Results: (1) The incidence of ESBLs producing E. coli and K. pneumoniae using cefotaxime as indicators were 18.8% (94/499) and 21.1% (64/303) respectively. Resistant to ceftazidime were 21 and 14 isolates, respectively. (2) ESBLs in surgical department, pediatrics and respiratory department were 32.9% (52/158), 14.6% (23/158), 12.7% (20/158), respectively. (3) ESBLs in sputum, urine, wounds, blood and body fluids were 27.8% (44/158), 22.2% (35/158), 20.3% (32/158), 12. 0% (19/ 158) and 12.0% (19/158), respectively. (4) The sensitive rates of ESBLs-producing E. coli isolates to imipenem, amikacin, ceftazidime, cefepime, gentamicin and cefoperazone/ sulbactam were 100.0%, 70.3%, 66.7%, 44.7%, 25.5% and 25.0%, respectively. The sensitive rates of ESBLs - producing K. pneumoniae isolates to imipenem, amikacin, ceftazidime, cefepime, cefoperazone/sulbactam and ciprofloxacin were 100.0%, 76.2%, 70.3%, 69.2%, 58.1% and 50.0%, respectively. Conclusions: The resistance rates of ESBLs-producing E. coli and K. Pneumoniae isolates to most antimicrobial agents were high. Antibiotics should be used rationally in the treatment of infections caused by ESBLs-producing strains.